Workflow
企业价值与销售额比率等财务指标
icon
Search documents
HCA Healthcare, Inc. (NYSE:HCA) Earnings Preview: A Closer Look at the Upcoming Q3 2025 Results
Financial Modeling Prep· 2025-10-24 00:00
Core Viewpoint - HCA Healthcare is preparing to release its third-quarter 2025 earnings, with expectations of stable earnings and revenue growth driven by patient volume increases and favorable payor mix [1][2][3][6] Financial Expectations - The company is expected to report earnings per share (EPS) of $5.65 and revenue of approximately $18.56 billion, while analysts project adjusted EPS of $5.72 and sales of $18.57 billion [1][2][6] - EBITDA is anticipated to meet or slightly exceed estimates, supported by a 2-3% increase in patient volumes [2][3] Operational Insights - A favorable payor mix is expected to benefit HCA, with lower-reimbursing payors remaining subdued [3] - Contributions from SDP/DPP and potential recognition of Texas CHIRP funds could boost annualized EBITDA by $150-$175 million [3] Financial Metrics - HCA's financial metrics include a price-to-earnings (P/E) ratio of approximately 17.84 and a price-to-sales ratio of about 1.42 [4][6] - The enterprise value to sales ratio is around 2.04, and the enterprise value to operating cash flow ratio is approximately 12.44 [4] - The company's earnings yield is about 5.61%, and its debt-to-equity ratio is approximately -10.55, indicating a significant level of debt compared to equity [5][6] - HCA's current ratio of around 0.98 suggests its ability to cover short-term liabilities with short-term assets [5]
Insights into Travel + Leisure Co's (TNL) Upcoming Quarterly Earnings
Financial Modeling Prep· 2025-10-21 15:00
Core Insights - Travel + Leisure Co (TNL) is set to release its quarterly earnings on October 22, 2025, with expected earnings per share of $1.74 and projected revenue of approximately $1.03 billion [1][4] Financial Metrics - TNL has a price-to-earnings (P/E) ratio of 10.01, indicating the market's valuation of its earnings [2][4] - The price-to-sales ratio stands at 0.99, suggesting that the market value is closely aligned with its sales [2][4] - The enterprise value to sales ratio is 2.37, reflecting the company's total valuation in relation to its sales [2] - The enterprise value to operating cash flow ratio is 15.58, showing the company's valuation relative to its cash flow from operations [3] - TNL has an earnings yield of 9.99%, indicating strong earnings generation per dollar invested [3] - The company has a negative debt-to-equity ratio of -6.56, suggesting more liabilities than equity [3] - TNL maintains a robust current ratio of 3.48, demonstrating its ability to effectively cover short-term liabilities [3][4]